4.8 Article

Chronic Stable Angina

期刊

NEW ENGLAND JOURNAL OF MEDICINE
卷 374, 期 12, 页码 1167-1176

出版社

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMcp1502240

关键词

-

资金

  1. Abiomed
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. Daiichi Sankyo
  5. Eli Lilly
  6. Janssen
  7. Stealth Peptides
  8. Medicines Company
  9. Angel Medical Systems
  10. Biotie Therapies
  11. Faculty Connection
  12. Merck
  13. Medscape
  14. Gilead Sciences

向作者/读者索取更多资源

A 73-year-old farmer with a 15-month history of stable angina presents for consultation. He has curtailed his farming activity to avoid chest discomfort, for which he uses nitroglycerin (0.4 mg sublingually) approximately 3 times per month. His heart rate is 59 beats per minute, and his blood pressure is 132/72 mm Hg. He had unstable angina 12 years earlier, and a drug-eluting stent was implanted in his left anterior descending artery; no other obstructive coronary artery disease was noted at that time. His medications include aspirin, lisinopril (20 mg daily) for hypertension, and atorvastatin (40 mg daily). How should this case be evaluated and managed?

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据